Fingolimod product-specific bioequivalence guidance
Fingolimod product-specific bioequivalence guidance
Fingolimod product-specific bioequivalence guidance
Fingolimod capsules 0.25 and 0.5 mg product-specific bioequivalence guidance
Entecavir product-specific bioequivalence guidance
Human medicines European public assessment report (EPAR): Eklira Genuair, aclidinium bromide, Date of authorisation: 20/07/2012, Revision: 22, Status: Authorised
Human medicines European public assessment report (EPAR): Duaklir Genuair, aclidinium bromide,formoterol, Date of authorisation: 19/11/2014, Revision: 17, Status: Authorised
Clinical trials in human medicines
Record of data processing activity in the context of selection and recruitment procedures
Summary of the Medicine Shortages SPOC Working Party meeting on 17 June 2025
Nitrosamine impurities
Report: European medicines regulatory network’s response to nitrosamine impurities in human medicines